CENPM and hepatocellular carcinoma: To demonstrate that LINC00882 aggravated the tumor behaviors of HCC through the modulation of miR-214-3p/CENPM axis, our group conducted rescue experiments via cotransfecting sh-LINC00882-1 or sh-NC and miR-214-3p inhibitors or NC inhibitors into HCC cells.